FIELD: medicine.
SUBSTANCE: data of clinical and laboratory studies are analysed. Probability index is determined according to formula: F=-0.20•X1+0.04•X2-0.05•X3+0.12•X4+7, where: F- probability index; X1 - level of antibody titer of IgG to Helicobacter pylori class, relative unit - ml-1; X2 - state anxiety, scores; X3 - half evacuation time, minutes; X4 - percentage of phagocytic mononuclear phagocyte, and if index is less then 0, possible complication is predicted.
EFFECT: enhancement of prediction accuracy of ulcer like functional dyspepsia at a young age.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING GASTRODUODENAL PATHOLOGY COURSE IN CHILDREN | 2011 |
|
RU2475754C2 |
METHOD FOR PREDICTING CLINICAL COURSE OF STOMACH- OR DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2003 |
|
RU2269132C2 |
METHOD FOR EVALUATING RISK OF EXACERBATIONS OF HELICOBACTERIOSIS | 2011 |
|
RU2481584C2 |
METHOD FOR EVALUATING RISK OF DUODENAL ULCER IN KHAKASS BY GENETIC ANALYSIS | 2014 |
|
RU2563828C1 |
METHOD OF PREDICTING PROGRESSION OF VIRAL HEPATITIS COURSE | 2009 |
|
RU2416362C2 |
METHOD FOR PREDICTING EFFICIENCY OF LOW-MINERALISED WATER TREATMENT OF PATIENTS WITH FUNCTIONAL DYSPEPSIA | 2007 |
|
RU2332929C1 |
METHOD OF PROBABILITY DETERMINATION OF BECOMING INFECTED WITH HELICOBACTER PYLORI | 2007 |
|
RU2360251C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
METHODS AND PRODUCTS FOR DIAGNOSTICS OF AUTOIMMUNE DISEASES AND GASTRIC CANCER, ASSOCIATED WITH ATROPHIC GASTRITIS | 2008 |
|
RU2519646C2 |
METHOD FOR CHRONIC INFECTIOUS MONONUCLEOSIS SEVERITY DETERMINATION IN CHILDREN | 2009 |
|
RU2406433C1 |
Authors
Dates
2008-11-27—Published
2007-01-25—Filed